SENOTHERAPEUTIX

Houston, US · 1 known investors

Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).

BiotechHealthtechLongevity